The outlook for consumer spending in the pharmacy sector in the six countries which account for almost 80% of the European Community's Gross Domestic Product is patchy, and the boom years of the late 1980s will not return, says a recent Marketing In Europe study from the Economist Intelligence Unit.
Belgium, France and the UK may see some recovery in consumer spending late in 1992, but for the Netherlands this year will mark a low point in economic growth, and Spain will be the most buoyant market. However, 1993 should see an improvement in sales of pharmaceuticals across the region, it says.
The study comments that health care has been one of the strongest consumer spending sectors in recent years, and pharmaceutical sales have been one of the star performers. Trends in consumer purchases are affected not only by the normal economic rules governing any discretionary purchase, but also by the interaction between publicly-funded purchases and those paid for directly by the consumer, as well as by the different administrative arrangements of national health systems.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze